Impaired fibrinolysis and risk of thromboembolism

Prog Cardiovasc Dis. 1991 Nov-Dec;34(3):179-92. doi: 10.1016/0033-0620(91)90012-b.

Authors

B Wiman¹, A Hamsten

Affiliation

¹ Department of Clinical Chemistry, King Gustaf V Research Institute, Karolinska Hospital, Stockholm, Sweden.

PMID: 1947123
DOI: 10.1016/0033-0620(91)90012-b

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Coronary Disease / etiology*
Fibrinolysis / physiology*
Humans
Insulin Resistance / physiology
Plasminogen Inactivators
Risk Factors
Thromboembolism / etiology*
Tissue Plasminogen Activator / physiology

Substances

Plasminogen Inactivators
Tissue Plasminogen Activator